Patient dropout is one of the most significant cost drivers in biomarker-selected clinical trials. Living Lab Reports® maintain a persistent, updating connection to enrolled patients — supporting retention, documenting engagement, and delivering informed consent content in a format that is measurable and reproducible for regulatory submissions. For health plans, the same infrastructure keeps members with hereditary findings informed and connected to appropriate care.